Standpoint Research
http://www.standpointresearch.comStandpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive six-year track record of more than 300 recommendations.
View Older Stories View More Recent Stories
-
Standpoint Research Starts Gogo (GOGO) at Buy
-
Standpoint Research Downgrades Corning (GLW) to Hold
-
Standpoint Research Upgrades VeriFone (PAY) to Buy
-
Standpoint Research Upgrades Gap, Inc. (GPS) to Buy
-
Standpoint Research Downgrades United Natural Foods (UNFI) to Hold
-
Standpoint Research Starts Opko Health (OPK) at Buy
-
Standpoint Research Starts Cooper Tire & Rubber (CTB) at Buy
-
Standpoint Research Upgrades Guess (GES) to Buy
-
Standpoint Research Downgrades Tutor Perini Corporation (TPC) to Hold
-
Standpoint Research Downgrades Flextronics (FLEX) to Hold
-
Standpoint Research Downgrades ANI Pharmaceuticals (ANIP) to Hold
-
Notable Analyst Rating Changes 5/20: (URBN) (CS) (JLL) Upgraded; (BEAV) (CMCM) (TNK) Downgraded
-
Standpoint Research Upgrades Goodyear Tire & Rubber (GT) to Buy
-
Standpoint Research Starts Johnson & Johnson (JNJ) at Sell
-
Standpoint Research Upgrades First Solar (FSLR) to Buy
-
Standpoint Research Downgrades Oshkosh (OSK) to Hold
-
Standpoint Research Downgrades Archer Daniels Midland (ADM) to Hold
-
Standpoint Research Downgrades McKesson (MCK) to Hold
-
Standpoint Research Starts Mercer International (MERC) at Buy
-
Standpoint Research Downgrades Lexmark International (LXK) to Hold
-
Standpoint Research Downgrades Jacobs Engineering (JEC) to Hold
-
Standpoint Research Downgrades Sotheby's (BID) to Hold
-
Standpoint Research Downgrades Nucor (NUE) to Hold
-
Standpoint Research Starts Tutor Perini Corporation (TPC) at Buy
-
Standpoint Research Downgrades Tesla Motors (TSLA) to Sell
-
Standpoint Research Downgrades Marvell (MRVL) to Hold
-
Standpoint Research Starts KapStone Paper & Packaging (KS) at Buy
-
Standpoint Research Downgrades Shoe Carnival (SCVL) to Hold
-
Standpoint Research Downgrades Buckle, Inc. (BKE) to Hold
-
Standpoint Research Downgrades Goodyear Tire & Rubber (GT) to Hold
-
Standpoint Research Starts Eagle Materials (EXP) at Accumulate
-
Notable Analyst Rating Changes 3/23: (HR) (IPHI) Upgraded; (SNX) (NVS) (HFC) Downgraded
-
Standpoint Research Downgrades Orbotech Ltd. (ORBK) to Hold
-
Standpoint Research Downgrades Newmont Mining Corp. (NEM) to Hold
-
Standpoint Research Downgrades Las Vegas Sands (LVS) to Hold
-
Standpoint Research Downgrades FedEx (FDX) to Hold
-
Standpoint Research Downgrades CA (CA) to Hold
-
Standpoint Research Downgrades Chico's, Inc. (CHS) to Hold
-
Standpoint Research Upgrades Nucor (NUE) to Buy
-
Standpoint Research Downgrades Emerson (EMR) to Hold
-
Notable 52-Week Highs and Lows 2/25: (DPZ) (FSLR) (MNOV) High; (RH) (RATE) (UNT) Low
-
Standpoint Research Downgrades First Solar (FSLR) to Hold
-
Standpoint Research Downgrades Silicon Motion Technology (SIMO) to Hold
-
Standpoint Research Downgrades Fossil (FOSL) to Hold
-
Standpoint Research Upgrades Marvell (MRVL) to Buy
-
Standpoint Research Downgrades Eaton Corporation (ETN) to Hold
-
Standpoint Research Upgrades Universal Health Services (UHS) to Buy
-
Standpoint Research Upgrades McKesson (MCK) to Buy
-
Standpoint Research Upgrades United Therapeutics Corp. (UTHR) to Buy
-
Standpoint Research Starts Gilead Sciences (GILD) at Buy

